Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (531-540 of 535) with videos related to

Pageof 54
Sort By:
You have reached the last page of results.This site can display upto 535 results.
Rheumatology (Oxford, England)|September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive diseaseDavid Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
Rheumatology (Oxford, England)|December 6, 2017
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational StudySébastien Peytrignet, Christopher P Denton, Mark Lunt, et al.
Annals of the Rheumatic Diseases|February 12, 2017
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)Ariane L Herrick, Xiaoyan Pan, Sébastien Peytrignet, et al.
Annals of the Rheumatic Diseases|January 8, 2018
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational StudyAriane L Herrick, Sebastien Peytrignet, Mark Lunt, et al.
Plos Genetics|July 23, 2011
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategyOlga Gorlova, Jose-Ezequiel Martin, Blanca Rueda, et al.
Pageof 54

Showing results (531-540 of 535) with videos related to

Sort By:
Pageof 54
You have reached the last page of results.This site can display upto 535 results.
Rheumatology (Oxford, England)|September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive diseaseDavid Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
Rheumatology (Oxford, England)|December 6, 2017
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational StudySébastien Peytrignet, Christopher P Denton, Mark Lunt, et al.
Annals of the Rheumatic Diseases|February 12, 2017
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)Ariane L Herrick, Xiaoyan Pan, Sébastien Peytrignet, et al.
Annals of the Rheumatic Diseases|January 8, 2018
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational StudyAriane L Herrick, Sebastien Peytrignet, Mark Lunt, et al.
Plos Genetics|July 23, 2011
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategyOlga Gorlova, Jose-Ezequiel Martin, Blanca Rueda, et al.
Pageof 54